NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,215 | +0.0% | 1,298 | -0.9% | 0.03% | +4.0% |
| Q2 2023 | $132,193 | +7.6% | 1,310 | -1.9% | 0.02% | 0.0% |
| Q1 2023 | $122,912 | +2.6% | 1,336 | +1.2% | 0.02% | -7.4% |
| Q4 2022 | $119,750 | +16.3% | 1,320 | -2.7% | 0.03% | 0.0% |
| Q3 2022 | $103,000 | -22.0% | 1,356 | -12.9% | 0.03% | -20.6% |
| Q2 2022 | $132,000 | +30.7% | 1,556 | +35.7% | 0.03% | +41.7% |
| Q1 2022 | $101,000 | +1.0% | 1,147 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $100,000 | +6.4% | 1,147 | 0.0% | 0.02% | -7.7% |
| Q3 2021 | $94,000 | -10.5% | 1,147 | 0.0% | 0.03% | -10.3% |
| Q2 2021 | $105,000 | +7.1% | 1,147 | 0.0% | 0.03% | -3.3% |
| Q1 2021 | $98,000 | -9.3% | 1,147 | 0.0% | 0.03% | -18.9% |
| Q4 2020 | $108,000 | +8.0% | 1,147 | 0.0% | 0.04% | -7.5% |
| Q3 2020 | $100,000 | 0.0% | 1,147 | 0.0% | 0.04% | -4.8% |
| Q2 2020 | $100,000 | +5.3% | 1,147 | 0.0% | 0.04% | -8.7% |
| Q1 2020 | $95,000 | – | 1,147 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |